Abstract
Background: Busulfan (Bu) is an anticancer drug with a variety of adverse effects for cancer patients. Oxidative stress has been considered as a common pathological mechanism and it has a key role in the initiation and progression of liver injury by Bu.
Aim: The study aimed to evaluate the antioxidant impact of L-Carnitine and Coenzyme Q10 and their protective role against oxidative stress damage in liver tissues.
Material and Methods: Thirty-six albino rats were divided equally into six groups. G1 (con), received I.P. injection of DMSO plus 1 ml of distilled water daily by oral gavages; G2 (Bu), received I.P. injection of Bu plus 1 ml of the distilled water daily; G3 (L-Car), received 1 ml of L-Car orally; G4 (Bu + L-Car) received I.P. injection of Bu plus 1 ml of L-Car, G5 (CoQ10) 1 ml of CoQ10 daily; and G6 (Bu + CoQ10) received I.P. injection of Bu plus 1 ml of CoQ10 daily.
Results: The recent data showed that Bu induced significant (P<0.05) elevation in serum ALT, AST, liver GSSG, NO, MDA and 8-OHDG, while showing significant (P<0.05) decrease in liver GSH and ATP. On the other hand, L-Carnitine and Coenzyme Q10 ameliorated the negative effects prompted by Bu. Immunohistochemical expression of caspase-3 in liver tissues reported pathological alterations in Bu group while also showed significant recovery in L-Car more than CoQ10.
Conclusion: L-Car, as well as CoQ10, can enhance the hepatotoxic effects of Bu by promoting energy production in oxidative phosphorylation process and by scavenging the free radicals.
Keywords: Busulfan, CoQ10, L-carnitine, oxidative stress, Caspase-3, hepatotoxicity.
Graphical Abstract
[PMID: 28444774]
[http://dx.doi.org/10.1016/S0027-5107(99)00034-2 ] [PMID: 10216211]
[http://dx.doi.org/10.1002/ajmg.c.30087 ] [PMID: 16602102]
[http://dx.doi.org/10.1016/j.bbamcr.2016.01.023 ] [PMID: 26828774]
[http://dx.doi.org/10.1016/j.bcp.2009.07.008 ] [PMID: 19632207]
[http://dx.doi.org/10.1016/j.clinre.2013.08.014 ] [PMID: 24239319]
[http://dx.doi.org/10.1093/ajcp/28.1.56 ] [PMID: 13458125]
[http://dx.doi.org/10.1081/JLC-100101783]
[http://dx.doi.org/10.1016/S0003-2697(02)00387-1 ] [PMID: 12441155]
[http://dx.doi.org/10.1006/abio.1993.1522 ] [PMID: 8109733]
[http://dx.doi.org/10.1016/S0300-483X(96)03553-6 ] [PMID: 9020199]
[http://dx.doi.org/10.18632/oncotarget.9821 ] [PMID: 27270647]
[http://dx.doi.org/10.1053/jhep.2002.33995 ] [PMID: 12085349]
[http://dx.doi.org/10.3324/haematol.2014.106542 ] [PMID: 24907357]
[http://dx.doi.org/10.1073/pnas.0705971104 ] [PMID: 17911255]
[http://dx.doi.org/10.1136/jcp.23.9.827-b ] [PMID: 5278972]
[http://dx.doi.org/10.1111/j.1440-1746.2003.03291.x ] [PMID: 14748882]
[http://dx.doi.org/10.1046/j.1442-200X.2001.01423.x ] [PMID: 11472585]
[http://dx.doi.org/10.1093/alcalc/agg109 ] [PMID: 12915513]
[http://dx.doi.org/10.1016/j.etap.2011.12.011 ] [PMID: 22222558]
[http://dx.doi.org/10.1186/s12937-016-0205-6 ] [PMID: 27716246]
[http://dx.doi.org/10.1159/000028359 ] [PMID: 10754451]